# Focus Areas

## Strategic Focus Areas for Development

Based on Dr. Eslami's research context and industry needs, here are the key areas to prioritize.

---

## 1. Ophthalmology AI Validation

### Why This Area
- Dr. Eslami's expertise is in ophthalmology (Mass Eye and Ear / Harvard)
- Rich history of AI applications (diabetic retinopathy, glaucoma, AMD)
- Clear failure cases documented (Google Health Thailand study)
- Standardized imaging modalities (fundus photos, OCT)

### Specific Use Cases

| Condition | AI Task | Data Type | Validation Need |
|-----------|---------|-----------|-----------------|
| **Diabetic Retinopathy** | Severity grading | Fundus photos | Cross-device, cross-population |
| **Glaucoma** | Risk assessment | OCT, fundus | External hospital validation |
| **AMD** | Detection/staging | OCT scans | Geographic diversity |
| **Cataracts** | Surgical readiness | Slit lamp images | Protocol differences |

### Why Start Here
- Well-defined problem space
- Existing models to validate
- Direct access to domain expert (Dr. Eslami)
- Published benchmarks exist

---

## 2. Model Generalization & Bias Detection

### The Core Problem
> "AI models that perform well during internal testing may fail to generalize to external environments — including different hospitals, geographic regions, races, and socioeconomic groups."

### Focus Components

#### 2.1 Covariate Shift Detection
- Detect when input data differs from training distribution
- Examples: different imaging devices, protocols, patient demographics
- **Tool**: Automated distribution comparison at inference time

#### 2.2 Subgroup Performance Analysis
- Break down model performance by:
  - Demographics (age, sex, race/ethnicity)
  - Clinical factors (disease severity, comorbidities)
  - Technical factors (device manufacturer, image quality)
- **Tool**: Dashboard with disaggregated metrics

#### 2.3 Fairness Metrics
- Equal opportunity (equal TPR across groups)
- Predictive parity (equal PPV across groups)
- Calibration across subgroups
- **Tool**: Automated bias reports

---

## 3. Regulatory Pathway Support

### FDA Landscape
- FDA has approved 500+ AI/ML medical devices
- External validation increasingly expected
- "Predetermined Change Control Plan" allows model updates

### Focus Components

#### 3.1 Validation Documentation
- Standardized performance reports
- Statistical significance testing
- Confidence intervals with proper methodology

#### 3.2 Dataset Characterization
- Document external validation set composition
- Compare to developer's training data
- Identify coverage gaps

#### 3.3 Continuous Monitoring Evidence
- Ongoing performance tracking
- Drift detection records
- Recalibration documentation

### Value Proposition
Companies seeking FDA approval face significant costs. Early external testing:
- Identifies model weaknesses before expensive trials
- Provides evidence of generalization
- Reduces regulatory risk

---

## 4. Privacy-Preserving Evaluation

### The Constraint
> "Many hospitals cannot or will not share their data with external developers due to privacy, regulatory, and ethical concerns."

### Approaches to Build

| Approach | Privacy Level | Complexity | Use Case |
|----------|---------------|------------|----------|
| **API-based inference** | High | Low | Quick validation |
| **On-premise containers** | Very High | Medium | Sensitive data |
| **Federated learning** | Very High | High | Multi-site training |
| **Synthetic data** | Medium | Medium | Initial testing |

### Priority: API-Based Inference
- Hospital sends anonymized images
- Model returns predictions only
- No raw data persists on platform
- Metrics computed locally at hospital

---

## 5. Interoperability & Standards

### Healthcare Data Standards

| Standard | Purpose | Relevance |
|----------|---------|-----------|
| **FHIR** | Healthcare data exchange | Patient records, observations |
| **DICOM** | Medical imaging | Radiology, ophthalmology images |
| **HL7** | Clinical messaging | Lab results, orders |
| **IHE** | Integration profiles | Workflow integration |

### Focus Components

#### 5.1 FHIR Integration
- Align with AWS HealthLake
- Support SMART on FHIR for authentication
- Enable structured data extraction

#### 5.2 DICOM Handling
- Parse DICOM headers for metadata
- Extract imaging parameters for shift detection
- Handle multi-frame and volumetric data

---

## Technology Focus Areas

### Cloud Infrastructure
- **AWS** as primary platform (HIPAA-eligible, SageMaker Serverless)
- **100% Serverless** for zero-cost-at-idle
- Infrastructure as Code (Terraform/CDK)

### Security
- HIPAA compliance from day one
- Zero-trust architecture
- Encryption everywhere

### ML Operations
- Model versioning
- A/B testing capability
- Rollback mechanisms

---

## Recommended 6-Month Roadmap

### Month 1: Foundation (Phase 1)
- [ ] Python evaluation SDK
- [ ] Basic metrics dashboard
- [ ] First ophthalmology model validation (with Dr. Eslami)

### Month 2-3: Platform (Phase 2)
- [ ] Model hosting service (SageMaker Serverless)
- [ ] Anonymization pipeline
- [ ] Multi-model comparison

### Month 4-5: Scale
- [ ] Data shift detection
- [ ] Subgroup analysis tools
- [ ] Second specialty expansion

### Month 6: Advanced (Phase 3)
- [ ] FDA report generator
- [ ] Federated learning pilot
- [ ] AWS Marketplace exploration

---

## Key Success Metrics

| Metric | Target (Year 1) |
|--------|-----------------|
| Models validated | 5-10 |
| Hospital partnerships | 2-3 |
| Validation reports generated | 20+ |
| Published case studies | 1-2 |
| Platform uptime | 99.9% |

---

## Immediate Next Steps

1. **Schedule kickoff** with Dr. Eslami
2. **Identify first model** for validation pilot
3. **Define data requirements** for MEEI collaboration
4. **Draft data use agreement** framework
5. **Set up AWS infrastructure** with HIPAA controls
